These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3354443)

  • 41. [Ventricular tachycardia and ventricular fibrillation following myocardial infarct: determinants of prognosis and disease course].
    Trappe HJ; Brugada P; Talajic M; Lezaun R; Wellens HJ
    Z Kardiol; 1988 Nov; 77(11):687-95. PubMed ID: 3213136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome.
    Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH
    Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arrhythmia control and other factors related to sudden death in coronary disease patients at intermediate risk.
    Blevins RD; Kerin NZ; Frumin H; Faitel K; Jarandilla R; Garfinkel C; Rubenfire M
    Am Heart J; 1986 Apr; 111(4):638-44. PubMed ID: 3953385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence and prognostic implications of severe ventricular arrhythmias during maximal exercise testing.
    Detry JM; Abouantoun S; Wyns W
    Cardiology; 1981; 68 Suppl 2():35-43. PubMed ID: 7317901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV; Grossbard CL; Graboys TB; Lown B
    Am J Cardiol; 1988 Nov; 62(14):18I-21I. PubMed ID: 2461071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G
    N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prognosis and management of patients with tachycardial heart arrhythmia ].
    Steinbach K
    Wien Med Wochenschr; 1984 Oct; 134(19-20):425-6. PubMed ID: 6516418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methodology for clinical trials with antiarrhythmic drugs to prevent cardiac death: US experience.
    Bigger JT
    Cardiology; 1987; 74 Suppl 2():40-56. PubMed ID: 3621278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Argon laser ablation of malignant ventricular tachycardia associated with coronary artery disease.
    Saksena S; Gielchinsky I; Tullo NG
    Am J Cardiol; 1989 Dec; 64(19):1298-304. PubMed ID: 2589195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sudden cardiac death during ambulatory Holter monitoring. Report on 3 documented cases.
    Rettig G; Sen S
    Jpn Heart J; 1984 Jul; 25(4):639-49. PubMed ID: 6502944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reproducibility of ventricular tachycardia suppression by antiarrhythmic drug therapy during serial electrophysiologic testing in coronary artery disease.
    Garan H; Stavens CS; McGovern B; Kelly E; Ruskin JN
    Am J Cardiol; 1986 Nov; 58(10):977-80. PubMed ID: 3776854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sudden cardiac death--an approach to management of the patient at risk.
    Podrid PJ; Blatt CM
    Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Which patient with sustained ventricular tachycardia is suited for long-term therapy with anti-arrhythmia drugs?].
    Steinbeck G
    Z Gesamte Inn Med; 1992 May; 47(5):195-201. PubMed ID: 1615729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Does the appearance of pro-arrhythmic response to anti-arrhythmic drugs have prognostic significance?].
    Trusz-Gluza M; Giec L; Dabrowski A; Kuch J; Piwowarska W; Pracka H; Sadowski Z; Wodniecki J; Filipecki A; Szydło K
    Kardiol Pol; 1992 May; 36(5):280-3. PubMed ID: 1625409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
    Volgman AS; Zheutlin TA; Mattioni TA; Parker MA; Kehoe RF
    Am J Cardiol; 1992 Sep; 70(7):758-63. PubMed ID: 1519526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
    Burckhardt D; Robertson A; Hoffmann A; Pfisterer M
    J Clin Pharmacol; 1991 Nov; 31(11):1105-8. PubMed ID: 1753016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiarrhythmic efficacy and hemodynamic effects of cibenzoline in patients with nonsustained ventricular tachycardia and left ventricular dysfunction.
    Seals AA; Haider R; Leon C; Francis M; Young JB; Roberts R; Pratt CM
    Circulation; 1987 Apr; 75(4):800-8. PubMed ID: 3549044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.